Effects of a combination treatment of KD5040 and L-dopa in a mouse model of Parkinson's disease

• Main Authors: Sora Ahn (Author), Taek-Jin Song (Author), Seong-Uk Park (Author), Songhee Jeon (Author), Jongpil Kim (Author), Joo-Young Oh (Author), Jaehwan Jang (Author), Sanhwa Hong (Author), Min-A Song (Author), Hye-Seoung Shin (Author), Young-Rim Jung (Author), Hi-Joon Park (Author)
• Format: Book
• Published: BMC, 2017-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Although the dopamine precursor L-3, 4-dihydroxyphenylalanine ( l -dopa) remains the gold standard pharmacological therapy for patients with Parkinson's disease (PD), long-term treatment with this drug has been known to result in several adverse effects, including l -dopa-in...